Skip to content
DataLookout
Menu

ANCARADNCT01937780

Anal Cancer Radiotherapy Study

StatusActive, Not Recruiting
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 6 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words
    • Study completion pushed from Dec 2025 to May 2027
    • Secondary endpoints: details revised at 1 of 4 entries
    • Publications: details revised at 1 of 1 entry
  2. Minor Study completion date: Dec 2024 to Dec 2025v7
  3. Minor Study completion date: Jan 2024 to Dec 2024v6
  4. Notable Primary completion date: Sep 2021 to Sep 2022v4
  5. Notable Start date: Aug 2013 to Oct 4, 2013
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jan 2024
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Disease-free survival
Timeframe: 3 years

Secondary (4)

Prediction of local recurrence
Biomarker ability to predict local recurrence rate
Improvement of faecal incontinence
Pain relief of palliative radiotherapy

Sites

1 site in 1 country

  • Oslo University HospitalOslo, Norway